TP53 and Alzheimer disease: The considerable accumulation of p53 due to the strong proteasome impairment observed in untreated AD mice confirms the ability of this substrate to trigger the apoptotic pathway; as expected, treatment with the probiotic mixture induced a considerable decrease in apoptotic activity, regulating the levels of proteasome substrates.